Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer. [PDF]
So HJ +5 more
europepmc +1 more source
Low FXIII activity levels in patients with vascular anomalies, not in patients with trauma-induced coagulopathy. [PDF]
Otsubo H +13 more
europepmc +1 more source
SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis. [PDF]
Westman H, Hammarström P, Nyström S.
europepmc +1 more source
Fibrin/MoS<sub>2</sub>-nanosheet conductive hydrogels with programmed time scales and pathways for bioresorption. [PDF]
Shukla V +10 more
europepmc +1 more source
Morphological Visualization of Thrombi During Catheter-Directed Fibrinolytic Therapy for Pulmonary Thromboembolism. [PDF]
Noda H +8 more
europepmc +1 more source
Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer. [PDF]
Song W +5 more
europepmc +1 more source
Coagulation biomarkers as predictors of transfusion outcomes in trauma patients. [PDF]
Jin Y, Fei L.
europepmc +1 more source
Bone-Healing Enhancement Using Particulate Biomaterials and Fibrin-Based Compounds: A Narrative Literature Review of Evidence in Animal Models. [PDF]
Bueno LMM +7 more
europepmc +1 more source

